These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15829128)

  • 21. Hyperprolactinaemia and verapamil: prevalence and potential association with hypogonadism in men.
    Romeo JH; Dombrowski R; Kwak YS; Fuehrer S; Aron DC
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):571-5. PubMed ID: 8977754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian hyperstimulation caused by gonadotroph cell adenoma: a case report and review of the literature.
    Kihara M; Sugita T; Nagai Y; Saeki N; Tatsuno I; Seki K
    Gynecol Endocrinol; 2006 Feb; 22(2):110-3. PubMed ID: 16603438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of Long-term Post-operative Testosterone Replacement Requirement Based on the Pre-operative Tumor Volume and Testosterone Level in Pituitary Macroadenoma.
    Lee CC; Chen CM; Lee ST; Wei KC; Pai PC; Toh CH; Chuang CC
    Sci Rep; 2015 Nov; 5():16194. PubMed ID: 26537232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperprolactinaemia.
    Prabhakar VK; Davis JR
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):341-53. PubMed ID: 17889620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolactin-secreting tumors in men: surgical cure.
    Pont A; Shelton R; Odell WD; Wilson CB
    Ann Intern Med; 1979 Aug; 91(2):211-3. PubMed ID: 572652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testosterone replacement therapy in male hypogonadism is not associated with increase of endothelin-1 levels.
    Kumanov P; Tomova A; Kirilov G
    Int J Androl; 2007 Feb; 30(1):41-7. PubMed ID: 16879620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Male hypogonadotropic hypogonadism (MHH) outpatient with testosterone deficiency syndrome: a case report].
    Taniguchi H; Kawa G; Kinoshita H; Matsuda T; Asai A
    Hinyokika Kiyo; 2009 Feb; 55(2):107-9. PubMed ID: 19301617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of aromatizable and unaromatizable androgen replacement in hypogonadal men on GH responsiveness.
    Gleeson HK; Shalet SM
    Clin Endocrinol (Oxf); 2009 Jan; 70(1):109-15. PubMed ID: 18549466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoandrogenaemia is associated with subclinical hypothyroidism in men.
    Kumar A; Chaturvedi PK; Mohanty BP
    Int J Androl; 2007 Feb; 30(1):14-20. PubMed ID: 16879621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pituitary macroadenomas associated with hyperprolactinaemia: immunocytochemical and in-situ hybridization studies.
    McNicol AM; Walker E; Farquharson MA; Teasdale GM
    Clin Endocrinol (Oxf); 1991 Sep; 35(3):239-44. PubMed ID: 1742881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperprolactinaemia.
    Patel SS; Bamigboye V
    J Obstet Gynaecol; 2007 Jul; 27(5):455-9. PubMed ID: 17701788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macroprolactinemia in childhood and adolescence: a cause of hyperprolactinemia.
    Tütüncüler F; Darendeliler F; Aygün M; Hekim N
    Turk J Pediatr; 2006; 48(2):143-7. PubMed ID: 16848115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of hypogonadotropic hypogonadism with tamoxifen in a patient with hyperprolactinemia resistant to dopamine agonists.
    López JM; Oestreicher E
    Fertil Steril; 2005 Sep; 84(3):756. PubMed ID: 16169415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A combined case of macroprolactinoma, growth hormone excess and Graves' disease.
    Hussein Z; Tress B; Colman PG
    Med J Malaysia; 2005 Jun; 60(2):232-6. PubMed ID: 16114168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of testosterone replacement therapy following radical prostatectomy.
    Khera M; Lipshultz LI
    Urol Clin North Am; 2007 Nov; 34(4):549-53, vi. PubMed ID: 17983894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mammary carcinoma in a patient with hyperprolactinemia].
    Gola M; Papi G; Tavernari V; Pesenti M; Ficarra G; Velardo A
    Minerva Endocrinol; 1997 Dec; 22(4):107-10. PubMed ID: 9586418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nodular pulmonary histoplasmosis in Cushing's disease: a case report and literature review.
    Kosseifi SG; Nassour DN; Shaikh MA; Sarubbi FA; Jordan RM; Peiris AN
    Tenn Med; 2007 Dec; 100(12):44-6. PubMed ID: 18183856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High estrogen in men after injectable testosterone therapy: the low T experience.
    Tan RS; Cook KR; Reilly WG
    Am J Mens Health; 2015 May; 9(3):229-34. PubMed ID: 24928451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia.
    O'Keane V
    J Psychopharmacol; 2008 Mar; 22(2 Suppl):70-5. PubMed ID: 18477623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.